Pharmacovigilance · ADR Intake
Report an adverse drug reaction
Yellow-card compatible intake. Every report is MedDRA-coded, severity-classified and routed to Rwanda FDA, WHO UMC (VigiBase) and the implicated marketing-authorisation holder within 24 hours for serious cases.
Acute pancreatitis · 10033645Nausea · 10028813Diarrhoea · 10012735
By submitting you confirm CIOMS-VI consent and Rwanda Law N° 003/2019 compliance.
Recent reports in triage
East-African pharmacovigilance hub
9 serious open
| ID | Drug | Reaction (MedDRA) | Severity | Pt | Country | Status |
|---|---|---|---|---|---|---|
| ADR-2026-04412 | Losartan/HCTZ 100/25 | Angioedema · MedDRA 10002424 | Serious | 62F | RW | Causality review |
| ADR-2026-04408 | Bedaquiline | QT prolongation · 10014054 | Serious | 9M | UG | PRAC escalated |
| ADR-2026-04401 | Semaglutide 1mg | Acute pancreatitis · 10033645 | Serious | 54M | KE | Disproportionality |
| ADR-2026-04395 | Tramadol 50mg | Serotonin syndrome · 10040108 | Serious | 38F | TZ | Closed · labelled |
| ADR-2026-04388 | Atorvastatin 40mg | Myopathy · 10028653 | Non-serious | 71M | RW | Routine |